Alnylam Pharmaceuticals Inc
ALNYToday
-0.09%
5 Days
+3.22%
1 Month
-12.18%
6 Months
-28.34%
Year to Date
-40.65%
1 Year
-48.06%
Johnson & Johnson Stock (JNJ) Moved Down by 3.49% on Jul 30: Key Drivers Unveiled
• Renewed talc litigation uncertainty exerts downward pressure on Johnson and Johnson's share price. • Increased competition and rising input costs challenge the MedTech division's operating margins. • Analysts lowered price targets amid regulatory concerns and pharmaceutical patent expiration risks.
Eli Lilly and Co Stock (LLY) Moved Down by 4.09% on Jul 30: Key Drivers Unveiled
• Eli Lilly shares declined due to profit-taking and increased competitive pressures in weight-loss markets. • Regulatory concerns regarding Medicare price negotiations are impacting institutional sentiment toward large-cap pharmaceutical stocks. • Technical factors, including broken moving averages and portfolio rebalancing, contributed to the intraday volatility.
AstraZeneca PLC Stock (AZN) Moved Down by 6.72% on Jul 9: A Full Analysis
• AstraZeneca shares fell after the Wainua drug failed a late-stage clinical trial. • The CARDIO-TTRansform trial did not meet its primary cardiovascular mortality reduction objectives. • High usage of competitor medication likely masked the drug's therapeutic efficacy in patients.
Alnylam Pharmaceuticals Inc's Score
Media Coverage
Analyst Rating
Alnylam Pharmaceuticals Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Alnylam Pharmaceuticals Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Capital World Investors | 12.21% |
| Fidelity Management & Research Company LLC | 11.30% |
| BlackRock Institutional Trust Company, N.A. | 5.27% |
| Capital Research Global Investors | 5.08% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 66.80% |
| Investment Advisor/Hedge Fund | 22.94% |
| Hedge Fund | 3.64% |
| Sovereign Wealth Fund | 1.83% |
Related Instruments
Popular Instruments
